Cargando…
Why Are There So Few FDA-Approved Therapeutics for Wound Healing?
Since the only and the milestone FDA approval of becaplermin gel (Regranex(TM), 0.01% human recombinant PDGF-BB) as a (diabetic) wound healing therapeutic more than 25 years ago, no new therapeutic (excluding physical therapies, devices, dressings, anti-microbial agents, or other preventive treatmen...
Autores principales: | Chen, Mei, Chang, Cheng, Levian, Brandon, Woodley, David T., Li, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606455/ https://www.ncbi.nlm.nih.gov/pubmed/37894789 http://dx.doi.org/10.3390/ijms242015109 |
Ejemplares similares
-
Why Did the FDA Approve These Advertisements?
por: Oaks, David
Publicado: (2006) -
Why are there so few (or so many) circulating coronaviruses?
por: Rice, Benjamin L., et al.
Publicado: (2021) -
Laws of biology: why so few?
por: Dhar, Pawan K., et al.
Publicado: (2009) -
The arrival of Mpox in Venezuela: Why so few cases?
por: Comegna, Mario, et al.
Publicado: (2023) -
Why Do Heterosporous Plants Have So Few Chromosomes?
por: Kinosian, Sylvia P., et al.
Publicado: (2022)